Logan Zemp
Papers
1
Total Citations
3
H-Index
1
About
Logan Zemp is a urologic oncologist whose research focuses on optimizing surgical outcomes for patients with advanced kidney cancer, particularly those undergoing cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC). His major contributions include providing contemporary, multi-institutional data on peri-operative morbidity and mortality associated with CN, addressing a critical gap in the literature. By analyzing outcomes across five centers, Zemp’s work helps clinicians better counsel patients on surgical risks, with his most-cited paper accumulating 3 citations to date. This research is notable for its practical impact on shared decision-making in a high-stakes clinical setting. Zemp’s scholarship underscores the importance of balancing the potential benefits of CN with its peri-operative complications, offering valuable insights for surgeons and oncologists treating mRCC. His work continues to inform evidence-based practice in urologic oncology, making him a key voice in the ongoing effort to refine surgical care for this challenging patient population.
Research Focus
Key Achievements
Top Papers
- 1